EOM Pharmaceutical Holdings, Inc. - IMUC

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2020 · Compare: Q2 2020
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
CAPTRUST FINANCIAL ADVISORS History Reduced 3 0 -22 -88.0% Q3 2020 Nov 17, 2020